These results highlight the potential of GLP1R and GCG as biomarkers for pancreatic cancer, given their marked overexpression in tumor tissues compared to normal tissues
Semaglutide binds to GLP-1 receptors throughout the body, triggering several physiological responses that support weight loss
If you want a broader primer on this treatment category, Peptides for Weight Loss explains how peptide-based therapies are discussed and why sourcing matters
For the narrower MACE-3 composite of cardiovascular death, myocardial infarction, or stroke, 27 events occurred among participants receiving retatrutide compared with 23 in the placebo group, resulting in a hazard ratio of 1.12 (95% CI: 0.64-1.96)
GIP engagement runs ahead at every dose and reaches roughly 50% occupancy by 15 mg
Rational combinations of targeted cancer therapies: background, advances and challenges